Symbol | Marktkapitalisierung | Preis | Veränderung % | Volumen | Relatives Volumen | KGV | EPS-Verd. TTM | EPS-Verd. Wachstum TTM YoY | Dividendenrendite % TTM | Analystenrating |
---|---|---|---|---|---|---|---|---|---|---|
LLYEli Lilly and Company | 762,85 B USD | 803,58 USD | −2,80% | 3,17 M | 0,87 | 87,90 | 9,14 USD | +68,74% | 0,63% | Kauf |
NVONovo Nordisk A/S DR | 493,51 B USD | 111,08 USD | +0,28% | 4,91 M | 1,02 | 36,02 | 3,08 USD | +28,16% | 0,93% | Kauf |
JNJJohnson & Johnson | 360,18 B USD | 149,60 USD | +0,19% | 8,39 M | 1,07 | 24,73 | 6,05 USD | +15,46% | 3,29% | Kauf |
ABBVAbbVie Inc. | 312,02 B USD | 176,57 USD | +0,22% | 4,39 M | 0,70 | 61,58 | 2,87 USD | −21,52% | 3,52% | Kauf |
MRKMerck & Company, Inc. | 262,55 B USD | 103,79 USD | +0,68% | 19,14 M | 1,44 | 21,74 | 4,77 USD | +165,21% | 2,99% | Kauf |
AZNAstraZeneca PLC DR | 210,38 B USD | 68,58 USD | +0,56% | 5,79 M | 1,12 | 32,96 | 2,08 USD | +10,04% | 2,13% | Kauf |
TMOThermo Fisher Scientific Inc | 205,49 B USD | 537,23 USD | +1,49% | 2,11 M | 0,88 | 33,69 | 15,95 USD | +4,49% | 0,29% | Starker Kauf |
NVSNovartis AG DR | 202,37 B USD | 101,68 USD | −0,30% | 1,12 M | 1,03 | 11,86 | 8,57 USD | +130,62% | 3,14% | Neutral |
ABTAbbott Laboratories | 199,29 B USD | 114,90 USD | −0,61% | 4,87 M | 1,09 | 34,94 | 3,29 USD | +11,75% | 1,90% | Kauf |
ISRGIntuitive Surgical, Inc. | 191,93 B USD | 538,86 USD | −2,10% | 1,43 M | 1,19 | 86,61 | 6,22 USD | +46,52% | 0,00% | Kauf |
DHRDanaher Corporation | 170,39 B USD | 235,91 USD | +2,52% | 2,63 M | 0,83 | 45,00 | 5,24 USD | −33,64% | 0,46% | Kauf |
AMGNAmgen Inc. | 149,24 B USD | 277,63 USD | +1,85% | 3,22 M | 0,58 | 35,55 | 7,81 USD | −44,46% | 3,30% | Kauf |
PFEPfizer, Inc. | 147,91 B USD | 26,10 USD | +1,44% | 37,1 M | 0,94 | 35,09 | 0,74 USD | −59,14% | 6,53% | Kauf |
SYKStryker Corporation | 145,29 B USD | 381,11 USD | −1,02% | 924,9 K | 0,83 | 40,86 | 9,33 USD | +38,34% | 0,83% | Kauf |
BSXBoston Scientific Corporation | 130,76 B USD | 88,72 USD | −1,50% | 4,88 M | 1,09 | 73,38 | 1,21 USD | +48,09% | 0,00% | Kauf |
SNYSanofi DR | 122,8 B USD | 48,43 USD | −0,06% | 1,62 M | 0,67 | 26,70 | 1,81 USD | −49,14% | 3,05% | Kauf |
VRTXVertex Pharmaceuticals Incorporated | 122,06 B USD | 473,98 USD | +2,57% | 1,26 M | 1,03 | — | −1,99 USD | −114,96% | 0,00% | Kauf |
BMYBristol-Myers Squibb Company | 119,07 B USD | 58,71 USD | −1,13% | 8,65 M | 1,04 | — | −3,60 USD | −191,22% | 4,04% | Neutral |
GILDGilead Sciences, Inc. | 112,9 B USD | 90,59 USD | −1,67% | 7,4 M | 1,13 | 1.021,31 | 0,09 USD | −98,10% | 3,32% | Kauf |
MDTMedtronic plc. | 107,66 B USD | 83,96 USD | −0,06% | 5,01 M | 0,83 | 25,62 | 3,28 USD | +6,47% | 3,31% | Kauf |
REGNRegeneron Pharmaceuticals, Inc. | 86,59 B USD | 788,00 USD | +1,29% | 1,03 M | 1,30 | 19,50 | 40,41 USD | +15,25% | 0,00% | Kauf |
ZTSZoetis Inc. | 80,38 B USD | 178,15 USD | +0,96% | 2,39 M | 0,93 | 33,49 | 5,32 USD | +8,17% | 0,98% | Starker Kauf |
GSKGSK plc DR | 69,85 B USD | 35,99 USD | +4,11% | 7,25 M | 1,85 | 23,42 | 1,54 USD | −57,75% | 4,46% | Neutral |
BDXBecton, Dickinson and Company | 64,48 B USD | 223,01 USD | +1,36% | 2,27 M | 1,10 | 37,54 | 5,94 USD | +19,60% | 1,73% | Starker Kauf |
TAKTakeda Pharmaceutical Company Limited DR | 43,54 B USD | 13,74 USD | +0,07% | 1,86 M | 1,26 | 22,79 | 0,60 USD | +36,22% | 4,61% | Kauf |
ALCAlcon Inc. | 43,21 B USD | 86,47 USD | −0,33% | 743,4 K | 1,02 | 35,43 | 2,44 USD | +177,80% | 0,31% | Kauf |
EWEdwards Lifesciences Corporation | 41,82 B USD | 70,90 USD | −0,88% | 4,15 M | 0,90 | 10,23 | 6,93 USD | +196,43% | 0,00% | Kauf |
AAgilent Technologies, Inc. | 41,38 B USD | 144,00 USD | +2,43% | 1,55 M | 0,74 | 32,55 | 4,42 USD | +5,34% | 0,67% | Kauf |
ARGXargenx SE DR | 37,69 B USD | 611,01 USD | −1,94% | 212,86 K | 0,74 | — | −3,50 USD | +51,16% | 0,00% | Starker Kauf |
GEHCGE HealthCare Technologies Inc. | 37,42 B USD | 81,90 USD | +0,81% | 2,37 M | 0,85 | 22,43 | 3,65 USD | +8,49% | 0,15% | Kauf |
IDXXIDEXX Laboratories, Inc. | 36,9 B USD | 450,68 USD | +3,44% | 783,78 K | 1,14 | 43,48 | 10,36 USD | +5,75% | 0,00% | Kauf |
RMDResMed Inc. | 35,93 B USD | 244,76 USD | +1,39% | 578 K | 0,81 | 32,45 | 7,54 USD | +22,71% | 0,84% | Kauf |
ALNYAlnylam Pharmaceuticals, Inc. | 33 B USD | 255,89 USD | −0,14% | 611,01 K | 0,99 | — | −2,62 USD | +36,82% | 0,00% | Kauf |
DXCMDexCom, Inc. | 30,63 B USD | 78,41 USD | +0,89% | 2,29 M | 0,66 | 47,00 | 1,67 USD | +84,80% | 0,00% | Kauf |
BNTXBioNTech SE DR | 29,18 B USD | 120,82 USD | −0,74% | 538,48 K | 0,64 | — | −2,15 USD | −118,72% | 0,00% | Kauf |
MTDMettler-Toledo International, Inc. | 27,05 B USD | 1.281,69 USD | +1,89% | 155,09 K | 1,22 | 34,56 | 37,09 USD | −5,47% | 0,00% | Neutral |
PHGKoninklijke Philips N.V. NY Registry Shares DR | 24,47 B USD | 26,28 USD | +0,27% | 627,07 K | 1,02 | — | −0,49 USD | +77,88% | 0,00% | Neutral |
ILMNIllumina, Inc. | 23,4 B USD | 147,53 USD | +4,56% | 2,12 M | 1,29 | — | −10,00 USD | −40,39% | 0,00% | Kauf |
WSTWest Pharmaceutical Services, Inc. | 23,33 B USD | 322,16 USD | −0,10% | 315,8 K | 0,81 | 47,79 | 6,74 USD | −9,03% | 0,25% | Kauf |
WATWaters Corporation | 23,28 B USD | 392,01 USD | +2,07% | 345,21 K | 0,61 | 37,41 | 10,48 USD | −4,77% | 0,00% | Neutral |
BGNEBeiGene, Ltd. DR | 22,92 B USD | 207,62 USD | +0,97% | 512,84 K | 1,06 | — | −8,24 USD | +11,11% | 0,00% | Starker Kauf |
BIIBBiogen Inc. | 22,8 B USD | 156,46 USD | −0,84% | 1,48 M | 1,09 | 14,13 | 11,07 USD | +10,06% | 0,00% | Kauf |
NTRANatera, Inc. | 22,15 B USD | 167,80 USD | −2,24% | 1,05 M | 0,94 | — | −1,77 USD | +60,70% | 0,00% | Kauf |
ZBHZimmer Biomet Holdings, Inc. | 21,79 B USD | 109,47 USD | +1,33% | 1,24 M | 0,95 | 20,86 | 5,25 USD | +132,63% | 0,89% | Neutral |
STESTERIS plc (Ireland) | 21,28 B USD | 215,63 USD | −0,12% | 434,54 K | 0,77 | 49,25 | 4,38 USD | −20,71% | 1,01% | Kauf |
TEVATeva Pharmaceutical Industries Limited DR | 20,16 B USD | 17,60 USD | +1,56% | 7,86 M | 0,95 | — | −0,85 USD | +57,10% | 0,00% | Kauf |
COOThe Cooper Companies, Inc. | 19,77 B USD | 99,26 USD | +0,57% | 1,72 M | 0,92 | 50,75 | 1,96 USD | +32,50% | 0,00% | Kauf |
PODDInsulet Corporation | 18,6 B USD | 265,12 USD | −0,13% | 437,16 K | 0,88 | 45,08 | 5,88 USD | +250,78% | 0,00% | Kauf |
ALGNAlign Technology, Inc. | 17,74 B USD | 237,57 USD | +2,25% | 548,67 K | 0,71 | 40,50 | 5,87 USD | +24,40% | 0,00% | Kauf |
MRNAModerna, Inc. | 17,57 B USD | 45,65 USD | +2,72% | 7,27 M | 0,90 | — | −5,82 USD | +37,62% | 0,00% | Neutral |
HOLXHologic, Inc. | 17,2 B USD | 75,79 USD | +0,60% | 2,33 M | 1,29 | 22,82 | 3,32 USD | +81,56% | 0,00% | Kauf |
UTHRUnited Therapeutics Corporation | 16,38 B USD | 367,00 USD | −0,72% | 246,45 K | 0,91 | 16,12 | 22,77 USD | +25,44% | 0,00% | Kauf |
BAXBaxter International Inc. | 16,26 B USD | 31,85 USD | +0,16% | 4,42 M | 1,11 | 138,90 | 0,23 USD | — | 3,27% | Neutral |
RPRXRoyalty Pharma plc | 15,33 B USD | 26,01 USD | +0,39% | 2,59 M | 0,88 | 10,17 | 2,56 USD | +538,81% | 3,24% | Starker Kauf |
VTRSViatris Inc. | 15,28 B USD | 12,80 USD | +0,63% | 6,69 M | 1,02 | — | −0,74 USD | −148,99% | 3,77% | Neutral |
RVTYRevvity, Inc. | 14,64 B USD | 120,29 USD | +3,29% | 709,49 K | 0,81 | 48,88 | 2,46 USD | −58,65% | 0,24% | Kauf |
GMABGenmab A/S DR | 14,46 B USD | 22,11 USD | +1,38% | 1,24 M | 1,08 | 21,30 | 1,04 USD | +10,05% | 0,00% | Kauf |
INCYIncyte Corporation | 13,89 B USD | 72,11 USD | −5,02% | 1,76 M | 1,01 | 510,69 | 0,14 USD | −92,50% | 0,00% | Kauf |
SMMTSummit Therapeutics Inc. | 13,76 B USD | 18,66 USD | +0,65% | 1,57 M | 0,80 | — | −0,28 USD | +82,45% | 0,00% | Starker Kauf |
NBIXNeurocrine Biosciences, Inc. | 13,07 B USD | 129,12 USD | +0,76% | 682,43 K | 0,85 | 34,59 | 3,73 USD | +99,71% | 0,00% | Starker Kauf |
INSMInsmed Incorporated | 13,02 B USD | 72,77 USD | −3,49% | 1,75 M | 1,21 | — | −5,56 USD | −5,41% | 0,00% | Starker Kauf |
BMRNBioMarin Pharmaceutical Inc. | 12,73 B USD | 66,81 USD | +0,10% | 1,79 M | 1,05 | 40,23 | 1,66 USD | +117,47% | 0,00% | Kauf |
RDYDr. Reddy's Laboratories Ltd DR | 12,34 B USD | 14,47 USD | −0,69% | 1,37 M | 0,88 | 18,87 | 0,77 USD | +3,36% | 0,55% | Neutral |
SRPTSarepta Therapeutics, Inc. | 12,32 B USD | 129,00 USD | +0,65% | 775,14 K | 0,58 | 107,16 | 1,20 USD | — | 0,00% | Starker Kauf |
TECHBio-Techne Corp | 12,3 B USD | 77,40 USD | +3,88% | 773,94 K | 1,09 | 82,49 | 0,94 USD | −38,45% | 0,43% | Kauf |
PCVXVaxcyte, Inc. | 11,47 B USD | 92,06 USD | −1,34% | 563,24 K | 0,54 | — | −4,68 USD | −40,18% | 0,00% | Starker Kauf |
EXASExact Sciences Corporation | 11,44 B USD | 61,80 USD | −1,06% | 1,34 M | 0,52 | — | −1,17 USD | +25,82% | 0,00% | Starker Kauf |
CTLTCatalent, Inc. | 11,32 B USD | 62,37 USD | +0,87% | 3,18 M | 1,23 | — | −2,27 USD | +58,54% | 0,00% | Neutral |
GMEDGlobus Medical, Inc. | 11,29 B USD | 82,92 USD | −0,48% | 628,14 K | 0,82 | 125,09 | 0,66 USD | −57,13% | 0,00% | Kauf |
SNNSmith & Nephew SNATS, Inc. DR | 10,88 B USD | 25,80 USD | +1,74% | 1,03 M | 1,73 | 37,05 | 0,70 USD | +37,57% | 2,86% | Kauf |
EXELExelixis, Inc. | 10,04 B USD | 35,17 USD | −1,81% | 1,74 M | 0,99 | 22,41 | 1,57 USD | +459,23% | 0,00% | Kauf |
QGENQiagen N.V. | 9,83 B USD | 44,32 USD | +2,07% | 669,16 K | 1,00 | 109,78 | 0,40 USD | −72,85% | 0,00% | Kauf |
BIOBio-Rad Laboratories, Inc. | 9,68 B USD | 345,60 USD | +6,18% | 228,4 K | 1,30 | — | −27,33 USD | −366,85% | 0,00% | Kauf |
BIO.BBio-Rad Laboratories, Inc. | 9,41 B USD | 337,08 USD | +0,32% | 105 | 0,25 | — | −27,33 USD | −366,85% | 0,00% | Kauf |
BRKRBruker Corporation | 9,32 B USD | 61,45 USD | +4,22% | 1,08 M | 0,76 | 29,59 | 2,08 USD | −3,92% | 0,34% | Kauf |
PENPenumbra, Inc. | 9,24 B USD | 240,86 USD | +1,53% | 170,7 K | 0,68 | 279,71 | 0,86 USD | −16,99% | 0,00% | Kauf |
MASIMasimo Corporation | 9,08 B USD | 169,52 USD | −0,16% | 454,82 K | 0,97 | 116,35 | 1,46 USD | −10,77% | 0,00% | Kauf |
ITCIIntra-Cellular Therapies Inc. | 9,01 B USD | 84,96 USD | +0,48% | 480,95 K | 1,28 | — | −0,86 USD | +47,14% | 0,00% | Starker Kauf |
ROIVRoivant Sciences Ltd. | 8,9 B USD | 12,22 USD | −1,13% | 2,93 M | 0,56 | 2,16 | 5,66 USD | — | 0,00% | Starker Kauf |
TFXTeleflex Incorporated | 8,69 B USD | 187,04 USD | +1,29% | 397,33 K | 0,86 | 37,18 | 5,03 USD | −41,08% | 0,74% | Kauf |
RGENRepligen Corporation | 8,67 B USD | 154,72 USD | +3,70% | 484,04 K | 1,05 | — | −0,15 USD | −108,32% | 0,00% | Kauf |
RVMDRevolution Medicines, Inc. | 8,58 B USD | 47,04 USD | −2,14% | 1,38 M | 0,49 | — | −3,59 USD | −10,04% | 0,00% | Starker Kauf |
ASNDAscendis Pharma A/S DR | 7,95 B USD | 132,42 USD | −0,44% | 495,4 K | 1,12 | — | −8,10 USD | +28,89% | 0,00% | Starker Kauf |
GKOSGlaukos Corporation | 7,65 B USD | 138,69 USD | −1,13% | 432,66 K | 0,82 | — | −2,96 USD | −10,22% | 0,00% | Kauf |
LEGNLegend Biotech Corporation DR | 7,62 B USD | 41,63 USD | +0,22% | 1,6 M | 1,27 | — | −1,91 USD | +35,99% | 0,00% | Starker Kauf |
JAZZJazz Pharmaceuticals plc | 7,3 B USD | 120,80 USD | −1,46% | 464,8 K | 0,95 | 17,40 | 6,94 USD | +1.051,97% | 0,00% | Kauf |
BLCOBausch + Lomb Corporation | 7,06 B USD | 20,05 USD | −0,10% | 562,33 K | 2,48 | — | −1,05 USD | −77,33% | 0,00% | Kauf |
MDGLMadrigal Pharmaceuticals, Inc. | 6,95 B USD | 318,44 USD | −0,75% | 295,33 K | 0,86 | — | −25,07 USD | −30,31% | 0,00% | Kauf |
NUVLNuvalent, Inc. | 6,67 B USD | 93,91 USD | −0,42% | 218,93 K | 0,76 | — | −3,48 USD | −71,14% | 0,00% | Starker Kauf |
LNTHLantheus Holdings, Inc. | 6,44 B USD | 92,58 USD | +4,00% | 621,63 K | 0,60 | 15,38 | 6,02 USD | +321,44% | 0,00% | Starker Kauf |
ELANElanco Animal Health Incorporated | 6,37 B USD | 12,88 USD | +3,04% | 4,28 M | 0,83 | 31,52 | 0,41 USD | — | 0,00% | Kauf |
HALOHalozyme Therapeutics, Inc. | 6,24 B USD | 49,06 USD | +1,36% | 867,19 K | 0,54 | 16,23 | 3,02 USD | +61,29% | 0,00% | Kauf |
CORTCorcept Therapeutics Incorporated | 6,21 B USD | 59,26 USD | −2,50% | 1,7 M | 2,33 | 47,13 | 1,26 USD | +55,35% | 0,00% | Starker Kauf |
IONSIonis Pharmaceuticals, Inc. | 6,09 B USD | 38,58 USD | +1,23% | 1,87 M | 1,25 | — | −2,44 USD | +14,63% | 0,00% | Kauf |
BPMCBlueprint Medicines Corporation | 6,01 B USD | 94,57 USD | −1,46% | 544,81 K | 1,00 | — | −2,11 USD | +77,09% | 0,00% | Kauf |
CYTKCytokinetics, Incorporated | 5,96 B USD | 50,50 USD | −0,90% | 881,15 K | 0,81 | — | −5,39 USD | +2,40% | 0,00% | Kauf |
MMSIMerit Medical Systems, Inc. | 5,95 B USD | 102,09 USD | −2,21% | 317,58 K | 0,94 | 50,01 | 2,04 USD | +18,62% | 0,00% | Kauf |
GRFSGrifols, S.A. DR | 5,68 B USD | 7,27 USD | −0,41% | 881,86 K | 0,53 | — | — | — | 0,00% | Neutral |
INSPInspire Medical Systems, Inc. | 5,68 B USD | 189,52 USD | −1,82% | 227,31 K | 0,55 | 176,08 | 1,08 USD | — | 0,00% | Kauf |
VKTXViking Therapeutics, Inc. | 5,61 B USD | 50,35 USD | −0,89% | 1,81 M | 0,59 | — | −0,94 USD | −1,31% | 0,00% | Starker Kauf |